Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough
- PMID: 8731026
- DOI: 10.1016/0928-8244(95)00123-9
Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough
Abstract
Antibody-binding epitopes on the Fim2 and Fim3 proteins of Bordetella pertussis, which have been associated with the induction of protective antibody, were located using sera from 12 patients with whooping cough and 4 vaccinated children. Fifteen epitopes were identified on both Fim2 and Fim3. In each case 9 were recognised by serum antibody from 11 or more infected patients. Epitopes associated with the highest IgG activity were not the same as those associated with the highest IgA activity. None of the vaccinated patients had detectable IgA. Most epitopes showed little or no evidence of serotype-specific responses, suggesting this is largely directed towards conformational epitopes. The reactivity of all but two epitopes was confirmed in an ELISA with patients' sera in which epitopes were re-synthesised as free soluble peptides. The short linear epitopes described may therefore be useful in the development of serodiagnostic assays but are unlikely vaccine candidates.
Similar articles
-
Bordetella pertussis isolates in Finland: serotype and fimbrial expression.BMC Microbiol. 2008 Sep 25;8:162. doi: 10.1186/1471-2180-8-162. BMC Microbiol. 2008. PMID: 18816412 Free PMC article.
-
Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.APMIS. 2009 Sep;117(9):660-71. doi: 10.1111/j.1600-0463.2009.02521.x. APMIS. 2009. PMID: 19703126 Clinical Trial.
-
Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.Clin Vaccine Immunol. 2014 Feb;21(2):165-73. doi: 10.1128/CVI.00641-13. Epub 2013 Dec 4. Clin Vaccine Immunol. 2014. PMID: 24307240 Free PMC article. Clinical Trial.
-
Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?Expert Rev Vaccines. 2005 Oct;4(5):757-78. doi: 10.1586/14760584.4.5.757. Expert Rev Vaccines. 2005. PMID: 16221076 Review.
-
Bordetella pertussis fimbriae (Fim): relevance for vaccines.Expert Rev Vaccines. 2014 Oct;13(10):1205-14. doi: 10.1586/14760584.2014.930667. Epub 2014 Aug 8. Expert Rev Vaccines. 2014. PMID: 25102891 Review.
Cited by
-
Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.Emerg Infect Dis. 2019 Jun;25(6):1196-1199. doi: 10.3201/eid2506.180240. Emerg Infect Dis. 2019. PMID: 31107218 Free PMC article.
-
Small mutations in Bordetella pertussis are associated with selective sweeps.PLoS One. 2012;7(9):e46407. doi: 10.1371/journal.pone.0046407. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029513 Free PMC article.
-
The History of Bordetella pertussis Genome Evolution Includes Structural Rearrangement.J Bacteriol. 2017 Mar 28;199(8):e00806-16. doi: 10.1128/JB.00806-16. Print 2017 Apr 15. J Bacteriol. 2017. PMID: 28167525 Free PMC article.
-
Population diversity among Bordetella pertussis isolates, United States, 1935-2009.Emerg Infect Dis. 2012 Aug;18(8):1248-55. doi: 10.3201/eid1808.120082. Emerg Infect Dis. 2012. PMID: 22841154 Free PMC article.
-
Identification and characterization of heparin binding regions of the Fim2 subunit of Bordetella pertussis.Infect Immun. 1998 May;66(5):2256-63. doi: 10.1128/IAI.66.5.2256-2263.1998. Infect Immun. 1998. PMID: 9573115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous